nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Distress—Hydroxyurea—head and neck cancer	0.0886	0.0889	CcSEcCtD
Carbimazole—Emotional distress—Hydroxyurea—head and neck cancer	0.0578	0.058	CcSEcCtD
Carbimazole—Emotional distress—Fluorouracil—head and neck cancer	0.0416	0.0418	CcSEcCtD
Carbimazole—Bone marrow depression—Hydroxyurea—head and neck cancer	0.0364	0.0365	CcSEcCtD
Carbimazole—Foetor hepaticus—Docetaxel—head and neck cancer	0.0225	0.0226	CcSEcCtD
Carbimazole—Liver disorder—Docetaxel—head and neck cancer	0.0187	0.0188	CcSEcCtD
Carbimazole—Throat sore—Docetaxel—head and neck cancer	0.0177	0.0178	CcSEcCtD
Carbimazole—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.0176	0.0176	CcSEcCtD
Carbimazole—Pancytopenia—Vinblastine—head and neck cancer	0.0161	0.0161	CcSEcCtD
Carbimazole—Ageusia—Docetaxel—head and neck cancer	0.0158	0.0158	CcSEcCtD
Carbimazole—Pancytopenia—Hydroxyurea—head and neck cancer	0.0146	0.0147	CcSEcCtD
Carbimazole—Neutropenia—Hydroxyurea—head and neck cancer	0.0144	0.0145	CcSEcCtD
Carbimazole—Agranulocytosis—Vinblastine—head and neck cancer	0.0141	0.0141	CcSEcCtD
Carbimazole—Oropharyngeal pain—Docetaxel—head and neck cancer	0.014	0.0141	CcSEcCtD
Carbimazole—Haemoglobin—Vinblastine—head and neck cancer	0.0136	0.0137	CcSEcCtD
Carbimazole—Haemorrhage—Vinblastine—head and neck cancer	0.0135	0.0136	CcSEcCtD
Carbimazole—Stomatitis—Hydroxyurea—head and neck cancer	0.0134	0.0135	CcSEcCtD
Carbimazole—Hepatocellular injury—Docetaxel—head and neck cancer	0.0128	0.0128	CcSEcCtD
Carbimazole—Haemoglobin—Hydroxyurea—head and neck cancer	0.0124	0.0125	CcSEcCtD
Carbimazole—Haemorrhage—Hydroxyurea—head and neck cancer	0.0123	0.0124	CcSEcCtD
Carbimazole—Alopecia—Vinblastine—head and neck cancer	0.012	0.012	CcSEcCtD
Carbimazole—Angiopathy—Hydroxyurea—head and neck cancer	0.0112	0.0112	CcSEcCtD
Carbimazole—Eosinophilia—Fluorouracil—head and neck cancer	0.011	0.011	CcSEcCtD
Carbimazole—Ill-defined disorder—Vinblastine—head and neck cancer	0.0109	0.011	CcSEcCtD
Carbimazole—Alopecia—Hydroxyurea—head and neck cancer	0.0109	0.0109	CcSEcCtD
Carbimazole—Malaise—Vinblastine—head and neck cancer	0.0106	0.0107	CcSEcCtD
Carbimazole—Leukopenia—Vinblastine—head and neck cancer	0.0106	0.0106	CcSEcCtD
Carbimazole—Pancytopenia—Fluorouracil—head and neck cancer	0.0105	0.0106	CcSEcCtD
Carbimazole—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00997	0.01	CcSEcCtD
Carbimazole—Discomfort—Vinblastine—head and neck cancer	0.00991	0.00995	CcSEcCtD
Carbimazole—Malaise—Hydroxyurea—head and neck cancer	0.00969	0.00973	CcSEcCtD
Carbimazole—Stomatitis—Fluorouracil—head and neck cancer	0.00965	0.00968	CcSEcCtD
Carbimazole—Leukopenia—Hydroxyurea—head and neck cancer	0.00962	0.00965	CcSEcCtD
Carbimazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.00942	0.00945	CcSEcCtD
Carbimazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.00924	0.00927	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00909	0.00912	CcSEcCtD
Carbimazole—Discomfort—Hydroxyurea—head and neck cancer	0.00904	0.00907	CcSEcCtD
Carbimazole—Haemoglobin—Fluorouracil—head and neck cancer	0.00893	0.00896	CcSEcCtD
Carbimazole—Haemorrhage—Fluorouracil—head and neck cancer	0.00889	0.00892	CcSEcCtD
Carbimazole—Infection—Hydroxyurea—head and neck cancer	0.00872	0.00874	CcSEcCtD
Carbimazole—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0086	0.00863	CcSEcCtD
Carbimazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00859	0.00862	CcSEcCtD
Carbimazole—Liver function test abnormal—Docetaxel—head and neck cancer	0.00856	0.00859	CcSEcCtD
Carbimazole—Skin disorder—Hydroxyurea—head and neck cancer	0.00852	0.00855	CcSEcCtD
Carbimazole—Feeling abnormal—Vinblastine—head and neck cancer	0.00793	0.00795	CcSEcCtD
Carbimazole—Alopecia—Fluorouracil—head and neck cancer	0.00785	0.00788	CcSEcCtD
Carbimazole—Pancytopenia—Docetaxel—head and neck cancer	0.00761	0.00764	CcSEcCtD
Carbimazole—Neutropenia—Docetaxel—head and neck cancer	0.00749	0.00752	CcSEcCtD
Carbimazole—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00723	0.00725	CcSEcCtD
Carbimazole—Hypersensitivity—Vinblastine—head and neck cancer	0.00709	0.00711	CcSEcCtD
Carbimazole—Stomatitis—Docetaxel—head and neck cancer	0.00697	0.00699	CcSEcCtD
Carbimazole—Jaundice—Docetaxel—head and neck cancer	0.00697	0.00699	CcSEcCtD
Carbimazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.00693	0.00696	CcSEcCtD
Carbimazole—Leukopenia—Fluorouracil—head and neck cancer	0.00693	0.00695	CcSEcCtD
Carbimazole—Agranulocytosis—Docetaxel—head and neck cancer	0.00667	0.00669	CcSEcCtD
Carbimazole—Myalgia—Fluorouracil—head and neck cancer	0.00659	0.00661	CcSEcCtD
Carbimazole—Discomfort—Fluorouracil—head and neck cancer	0.00651	0.00653	CcSEcCtD
Carbimazole—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00646	0.00648	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—head and neck cancer	0.00645	0.00647	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—head and neck cancer	0.00641	0.00644	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—head and neck cancer	0.00641	0.00644	CcSEcCtD
Carbimazole—Infection—Fluorouracil—head and neck cancer	0.00627	0.00629	CcSEcCtD
Carbimazole—Nervous system disorder—Fluorouracil—head and neck cancer	0.00619	0.00621	CcSEcCtD
Carbimazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00618	0.0062	CcSEcCtD
Carbimazole—Headache—Vinblastine—head and neck cancer	0.00603	0.00605	CcSEcCtD
Carbimazole—Angiopathy—Docetaxel—head and neck cancer	0.00582	0.00584	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00575	0.00577	CcSEcCtD
Carbimazole—Nausea—Vinblastine—head and neck cancer	0.00571	0.00573	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—head and neck cancer	0.00567	0.00569	CcSEcCtD
Carbimazole—Rash—Hydroxyurea—head and neck cancer	0.00553	0.00555	CcSEcCtD
Carbimazole—Dermatitis—Hydroxyurea—head and neck cancer	0.00553	0.00554	CcSEcCtD
Carbimazole—Headache—Hydroxyurea—head and neck cancer	0.0055	0.00551	CcSEcCtD
Carbimazole—Nausea—Hydroxyurea—head and neck cancer	0.00521	0.00523	CcSEcCtD
Carbimazole—Feeling abnormal—Fluorouracil—head and neck cancer	0.0052	0.00522	CcSEcCtD
Carbimazole—Urticaria—Fluorouracil—head and neck cancer	0.00502	0.00503	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—head and neck cancer	0.005	0.00502	CcSEcCtD
Carbimazole—Body temperature increased—Fluorouracil—head and neck cancer	0.00499	0.00501	CcSEcCtD
Carbimazole—Myalgia—Docetaxel—head and neck cancer	0.00475	0.00477	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—head and neck cancer	0.00475	0.00477	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00472	0.00474	CcSEcCtD
Carbimazole—Hypersensitivity—Fluorouracil—head and neck cancer	0.00465	0.00467	CcSEcCtD
Carbimazole—Infection—Docetaxel—head and neck cancer	0.00453	0.00454	CcSEcCtD
Carbimazole—Nervous system disorder—Docetaxel—head and neck cancer	0.00447	0.00448	CcSEcCtD
Carbimazole—Pruritus—Fluorouracil—head and neck cancer	0.00447	0.00448	CcSEcCtD
Carbimazole—Thrombocytopenia—Docetaxel—head and neck cancer	0.00446	0.00448	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—head and neck cancer	0.00443	0.00444	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00415	0.00417	CcSEcCtD
Carbimazole—Rash—Fluorouracil—head and neck cancer	0.00398	0.00399	CcSEcCtD
Carbimazole—Dermatitis—Fluorouracil—head and neck cancer	0.00398	0.00399	CcSEcCtD
Carbimazole—Headache—Fluorouracil—head and neck cancer	0.00396	0.00397	CcSEcCtD
Carbimazole—Feeling abnormal—Docetaxel—head and neck cancer	0.00376	0.00377	CcSEcCtD
Carbimazole—Nausea—Fluorouracil—head and neck cancer	0.00375	0.00376	CcSEcCtD
Carbimazole—Body temperature increased—Docetaxel—head and neck cancer	0.0036	0.00361	CcSEcCtD
Carbimazole—Hypersensitivity—Docetaxel—head and neck cancer	0.00336	0.00337	CcSEcCtD
Carbimazole—Pruritus—Docetaxel—head and neck cancer	0.00322	0.00324	CcSEcCtD
Carbimazole—Rash—Docetaxel—head and neck cancer	0.00287	0.00288	CcSEcCtD
Carbimazole—Dermatitis—Docetaxel—head and neck cancer	0.00287	0.00288	CcSEcCtD
Carbimazole—Headache—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Carbimazole—Nausea—Docetaxel—head and neck cancer	0.00271	0.00272	CcSEcCtD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—head and neck cancer	0.000826	0.248	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AREG—head and neck cancer	0.000317	0.0952	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—head and neck cancer	0.000272	0.0816	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NOTCH1—head and neck cancer	0.000235	0.0705	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—head and neck cancer	0.000137	0.0413	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—head and neck cancer	0.000101	0.0302	CbGpPWpGaD
Carbimazole—TPO—Metabolism—UROD—head and neck cancer	9.3e-05	0.0279	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A1—head and neck cancer	9.25e-05	0.0278	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.48e-05	0.0225	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.38e-05	0.0222	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—NAT2—head and neck cancer	6.88e-05	0.0207	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	6.79e-05	0.0204	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	6.35e-05	0.0191	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	6.28e-05	0.0188	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.06e-05	0.0182	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	5.97e-05	0.0179	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	4.23e-05	0.0127	CbGpPWpGaD
Carbimazole—TPO—Metabolism—NAT2—head and neck cancer	3.86e-05	0.0116	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	3.4e-05	0.0102	CbGpPWpGaD
Carbimazole—TPO—Metabolism—DPYD—head and neck cancer	3.38e-05	0.0102	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	3.35e-05	0.0101	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	3.22e-05	0.00967	CbGpPWpGaD
Carbimazole—TPO—Metabolism—YAP1—head and neck cancer	3.21e-05	0.00964	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	3.18e-05	0.00954	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UROD—head and neck cancer	2.83e-05	0.00851	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	2.61e-05	0.00783	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	2.58e-05	0.00774	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	2.24e-05	0.00672	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.2e-05	0.0066	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMS—head and neck cancer	1.93e-05	0.00579	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	1.92e-05	0.00577	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—head and neck cancer	1.91e-05	0.00572	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	1.85e-05	0.00557	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GPX1—head and neck cancer	1.83e-05	0.00548	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—head and neck cancer	1.81e-05	0.00543	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	1.67e-05	0.00503	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	1.51e-05	0.00452	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	1.51e-05	0.00452	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	1.27e-05	0.0038	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.25e-05	0.00375	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.24e-05	0.00371	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NAT2—head and neck cancer	1.18e-05	0.00353	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—head and neck cancer	1.07e-05	0.00323	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	1.07e-05	0.00321	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DPYD—head and neck cancer	1.03e-05	0.0031	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—YAP1—head and neck cancer	9.79e-06	0.00294	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—head and neck cancer	9.37e-06	0.00281	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.36e-06	0.00221	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—head and neck cancer	6.61e-06	0.00199	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.41e-06	0.00193	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMS—head and neck cancer	5.88e-06	0.00176	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—head and neck cancer	5.81e-06	0.00174	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GPX1—head and neck cancer	5.56e-06	0.00167	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—head and neck cancer	5.51e-06	0.00165	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—head and neck cancer	5.4e-06	0.00162	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.53e-06	0.00136	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—head and neck cancer	3.28e-06	0.000983	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—head and neck cancer	2.86e-06	0.000858	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—head and neck cancer	2.02e-06	0.000605	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—head and neck cancer	1.65e-06	0.000494	CbGpPWpGaD
